NIFTY
-11.35  -0.10%
 11521.05
S&P BSE SENSEX
23.28  0.06%
 38386.75
Lupin Ltd.
NSE : LUPIN BSE : 500257 ISIN code : INE326A01037
on 20-Mar-2019
NSE
-1.65    -0.22%
Rs. 753.40
 
Days Low
Rs. 748
Days High
Rs. 759.2

Open Rs. 756
 
52 week Low
Rs. 723.55
52 week High
Rs.986
 
 
Bid :                 752.55 (50)
Offer :        0.00 (0)
BSE
Rs.752.55
-2.75    -0.36%
on 20-Mar-2019
BSE
-2.75    -0.36%
Rs. 752.55
 
Days Low
Rs. 747.05
Days High
Rs. 759.9

Open Rs. 758
 
52 week Low
Rs. 723.65
52 week High
Rs.986.1
 
 
Bid :                 752.55 (50)
Offer :        0.00 (0)
NSE
Rs.753.40
-1.65    -0.22%
 
 
Last Price (Rs.)  752.55 Value  64378990.00
Net Change (Rs.)  -2.75 Best Buy  752.55
Volume  85537 Best Sell  0.00
Prev.Close (Rs.)  755.30 Best Quantity  50
Open (Rs.)  756.00 Sell Quantity  0
High (Rs.)  759.20 52-Week High (Rs.)  986.00
Low (Rs.)  748.00 52-Week Low (Rs.)  723.55
Face Value (Rs.)  2 Market Cap.(Rs/ Mn)  340516.23
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital904.20 903.20 901.20 
Share Capital904.20 903.20 901.20 
Share Capital904.20 903.20 901.20 
Share Capital904.20 903.20 901.20 
Share Capital904.20 903.20 901.20 
Currents Investments2325.90 21120.00 0.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 474.35 1138125 77.46 0.00 0.42
Piramal Enterprises 2612.25 481816 1083.86 90.82 0.96
Dr. Reddys Lab 2747.25 456225 749.81 80.45 0.73
Aurobindo Pharma 777.25 455397 188.62 25.12 0.32
Divis Lab 1677.55 445337 251.75 51.21 0.60
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2018Sep 2018Jun 2018
Net Sales30928.0027125.5025791.10
Operating Profit8195.606950.506738.80
PBDT4673.606847.706666.60
Net Profit1418.204247.504294.80
More> 
 
Company News
3/18/2019 12:00:00 AM
U.S. FDA Classifies The Inspection Of Lupin'S Somerset (NJ, US) Facil...
3/18/2019 12:00:00 AM
USFDA classifies Lupin's Somerset facility as ‘Official Action Indicat...
3/13/2019 12:00:00 AM
U.S. FDA Classifies The Inspection At The Company''s Mandideep (Unit ...
More>
 
Ratios
   Earnings Per Share (Rs)29.74 
   Book NAV/Share(Rs)344.47 
   PAT Margin (%)13.33 
   Asset Turnover(x)0.55 
   PER(x)24.76 
   Yield(%)0.68 
   EV/Core EBITDA(x)14.97 
   M Cap / Sales3.30 
   Net Sales Growth(%)-20.90 
   PAT Growth(%)-57.19 
   Total Debt/Equity(x)0.00 
   Current Ratio(x)3.73 
   Quick Ratio(x)2.80 
   Total Debt/Mcap(x)0.00 
More>